Nigella Sativa Supplementation Accelerates Recovery from Mild COVID-19: First Randomized Controlled Trial

por Koshak, Abdulrahman, Koshak, Emad A, Mobeireek, Abdullah F, Badawi, Mazen A, Wali, Siraj O, Malibary, Husam M, Atwah, Ali F, Alhamdan, Meshari M, Almalki, Reem A, Madani, Tariq A
Publicado 2021

Nigella sativa supplementation to treat symptomatic mild COVID-19: A structured summary of a protocol for a randomised, controlled, clinical trial

por Koshak, Abdulrahman E., Koshak, Emad A., Mobeireek, Abdullah F., Badawi, Mazen A., Wali, Siraj O., Malibary, Husam M., Atwah, Ali F., Alhamdan, Meshari M., Almalki, Reem A., Madani, Tariq A.
Publicado 2020

Nigella sativa for the treatment of COVID-19: An open-label randomized controlled clinical trial

por Koshak, Abdulrahman E., Koshak, Emad A., Mobeireek, Abdullah F., Badawi, Mazen A., Wali, Siraj O., Malibary, Husam M., Atwah, Ali F., Alhamdan, Meshari M., Almalki, Reem A., Madani, Tariq A.
Publicado 2021